Search Results - Peter Meldgaard
- Showing 1 - 14 results of 14
-
1
ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach by Lærke Rosenlund Nielsen, Simone Stensgaard, Peter Meldgaard, Boe Sandahl Sorensen
Published in Cancer Treatment and Research Communications (2024-01-01)Get full text
Article -
2
Gene Expression of the EGF System—a Prognostic Model in Non–Small Cell Lung Cancer Patients Without Activating EGFR Mutations by Birgitte Sandfeld-Paulsen, Birgitte Holst Folkersen, Torben Riis Rasmussen, Peter Meldgaard, Boe S. Sorensen
Published in Translational Oncology (2016-08-01)Get full text
Article -
3
-
4
-
5
EGFR transcription in non‐small‐cell lung cancer tumours can be revealed in ctDNA by cell‐free chromatin immunoprecipitation (cfChIP) by Christoffer Trier Månsson, Johan Vad‐Nielsen, Peter Meldgaard, Anders Lade Nielsen, Boe Sandahl Sorensen
Published in Molecular Oncology (2021-11-01)Get full text
Article -
6
Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients by Anne Winther-Larsen, Joan Fledelius, Christina Demuth, Catharina M Bylov, Peter Meldgaard, Boe S Sorensen
Published in Translational Oncology (2016-12-01)Get full text
Article -
7
-
8
The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment by Christina Demuth, Anne Tranberg Madsen, Britta Weber, Lin Wu, Peter Meldgaard, Boe Sandahl Sorensen
Published in BMC Cancer (2018-02-01)Get full text
Article -
9
Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer by Torben Steiniche, Jeanette Baehr Georgsen, Peter Meldgaard, Anne C. Deitz, Mark Ayers, M. Catherine Pietanza, Ke Zu
Published in Frontiers in Oncology (2024-01-01)Get full text
Article -
10
-
11
In vitro size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies by Christoffer Trier Maansson, Louise Skov Thomsen, Laura Stokkebro, Julie Gabe Dissing, Maiken Parm Ulhoi, Anders Lade Nielsen, Peter Meldgaard, Boe Sandahl Sorensen
Published in The Journal of Liquid Biopsy (2024-06-01)Get full text
Article -
12
Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer usi... by Theresa May, Michelle S Clement, Harkanwal Halait, Alexander Kohlmann, Milena Kohlmann, Jason Lai, Nitta Lee, Xiaocheng Li-Sucholeiki, Peter Meldgaard, Snehal Joshi, Sidney Scudder, Neelima Shrestha, Boe Sorensen, Marilyn Kiral, Patrick O'Donnell
Published in PLoS ONE (2024-01-01)Get full text
Article -
13
Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer usi... by Theresa May, Michelle S. Clement, Harkanwal Halait, Alexander Kohlmann, Milena Kohlmann, Jason Lai, Nitta Lee, Xiaocheng Li-Sucholeiki, Peter Meldgaard, Snehal Joshi, Sidney Scudder, Neelima Shrestha, Boe Sorensen, Marilyn Kiral, Patrick O’Donnell
Published in PLoS ONE (2024-01-01)Get full text
Article -
14
Impact of multidisciplinary team discrepancies on comparative lung cancer outcome analyses and treatment equality by Torben Riis Rasmussen, Anja Gouliaev, Erik Jakobsen, Karin Hjorthaug, Lene Unmack Larsen, Peter Meldgaard, Jesper Thygesen, Rana Bibi, Lars B. Møller, Arman Arshad, Birgitte Folkersen, Anette Højsgaard, Zaigham Saghir, Klaus R. Larsen, Jesper Ravn
Published in BMC Cancer (2024-11-01)Get full text
Article
